Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition
Evaluation of the Effectiveness and Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition
1 other identifier
interventional
1,051
1 country
2
Brief Summary
Objectives: To evaluate the effectiveness, and cost-effectiveness, of three hospitalized patient care strategies in relation to disease-related malnutrition (DRM) hospital admissions based on results such as length of stay of the index admission, and from admission until one year after admission, mortality rate, appearance of complications, changes in weight and nutritional state, changes in their health related quality of life and functional status, readmissions, use of health services resources (primary care, hospital and emergency consultations) and costs. Methodology: Intervention study involving three hospitals with three branches in which, after nutritional screening in all centers, the first branch / hospital includes a intervention strategy for nutritional improvement in patients who after screening are identified as having DRE or at risk of DRE, and follow-up of other patients; a second cohort / hospital will include similar patients in which if there is any nutritional intervention it will be carried out by demand of the medical staff in charge of the patient; and a third branch /hospital in which the usual practice of the center will be followed without any explicit intervention. Subjects of the study: At least 300 patients in each center admitted to the digestive services, due to digestive pathologies, and surgery services due to tumor and digestive system pathologies. In all patients, sociodemographic and clinical data will be collected and of the outcomes described above during admission and until the year of follow-up. Statistical analysis: through appropriate multiple regression models for each outcome variable and with adjustments through propensity scores to compare the three centers based on each outcome parameter. A cost-effectiveness analysis will be carried out through of the incremental cost for each year of quality-adjusted life (QALY) .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2020
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2019
CompletedFirst Posted
Study publicly available on registry
December 6, 2019
CompletedStudy Start
First participant enrolled
June 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedSeptember 21, 2023
September 1, 2023
2 years
December 2, 2019
September 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Mean weight changes
Mean weight changes from admission to discharge, at hospital at the index admission, and until one year of follow up
Index hospital admission and 12 months follow up
Mean length of stay
Mean length of stay at the index admission
Index hospital admission
Mortality rate
Mortality rate at different points in time
Index hospital admission to 12 months follow up
Secondary Outcomes (7)
Number of Participants with complications
Index hospital admission to 12 months follow up
Number of Participants with Hospital readmissions
Index hospital discharge to 12 months follow up
Other health care resources use
Index hospital discharge to 12 months follow up
Number of Participants with Adverse effects of the nutrition program
Index hospital admission to12 months follow up
Costs
Index hospital admission to12 months follow up
- +2 more secondary outcomes
Study Arms (3)
Intervention arm
ACTIVE COMPARATORThe "Intervention arm" includes an intervention in the groups of patients who, after screening, are identified as having disease-related malnutrition (DRM) or at risk of DRM, and a follow-up of the rest of the patients
By demand arm
PLACEBO COMPARATORThe "By demand arm" will include patients in whom the nutritional intervention, if given, is performed by demand by the medical staff responsible for each patient.
Usual care arm
PLACEBO COMPARATORIn the "Usual care arm" usual hospital practice is followed without any explicit nutritional intervention
Interventions
The intervention will be carried out by the Endocrinology and Nutrition Service of hospital 1, where the type of therapeutic action to be developed will be established (Dietary advice, Oral Nutritional Supplementation (SNO), Enteral Feeding or Parenteral Nutrition). The Total Calorie Balance, calories from feeding or with Oral Nutritional Supplementation (ONS), enteral, parenteral, and protein intake will be recorded. The steps to be taken are the following: A.-In patients with preserved oral intake capacity apply the most appropriate dietary measures in each case. B.-If the oral route is contraindicated, it will be assessed if it is possible to use the gastrointestinal tract and enteral nutrition will begin until the patient recovers the oral intake capacity. C.-If the use of the gastrointestinal tract is not indicated, parenteral nutrition will be assessed until digestive function is restored.
In the "By demand" arm, it is by clinical judgement of the doctor responsible of each patient that can be demanded a nutritional intervention to the nutrition unit of the center's endocrinology service that will judge the type of intervention. This is their usual care right now
In th "Usual care" arm, there is no explicit nutritional intervention performed at this time for those patients and, therefore, their usual regular nutritional care will be provide
Eligibility Criteria
You may not qualify if:
- Pathologies to be included according to ICD 10 criteria : A-Digestive pathologies: acute pancreatitis, ulcerative colitis, Crohn's disease, Inflammatory bowel disease.
- Pathologies to be included according to ICD 10 criteria : .-Oncological pathologies (surgery or admissions at follow up for oncologic patients): esophageal, gastric, colon and rectum cancers , pancreatic cancer, and ulcerative colitis and Crohn's disease admitted with surgical indication.
- Patients older than 18 years and who are recruited in the first 48 hours after admission
- Patients who sign the informed consent.
- Patients with serious organic or psychopathological problems or in a terminal situation;
- Patients with neurosensory problems,
- Patients that do not understand the Spanish or Basque language,
- Patients that prevent them from giving their consent
- Patients unable to complete the questionnaires used in the study.
- Patients who are to have surgery by colon or rectum cancers detected by screening (not applicable if they are later admitted by complications of their oncological disease)
- Age under 18,
- Pregnancy,
- Admission to critical units,
- Admission to a short stay unit (\<72 hours)
- Admission to a psychiatry,
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hospital Universitario Donostia
Donostia / San Sebastian, Spain
Hospital Galdakao-Usansolo
Galdakao, Spain
Related Publications (9)
Bally MR, Blaser Yildirim PZ, Bounoure L, Gloy VL, Mueller B, Briel M, Schuetz P. Nutritional Support and Outcomes in Malnourished Medical Inpatients: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016 Jan;176(1):43-53. doi: 10.1001/jamainternmed.2015.6587.
PMID: 26720894BACKGROUNDCederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S, Muscaritoli M, Nyulasi I, Ockenga J, Schneider SM, de van der Schueren MA, Singer P. Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr. 2015 Jun;34(3):335-40. doi: 10.1016/j.clnu.2015.03.001. Epub 2015 Mar 9.
PMID: 25799486BACKGROUNDBaldwin C, Kimber KL, Gibbs M, Weekes CE. Supportive interventions for enhancing dietary intake in malnourished or nutritionally at-risk adults. Cochrane Database Syst Rev. 2016 Dec 20;12(12):CD009840. doi: 10.1002/14651858.CD009840.pub2.
PMID: 27996085BACKGROUNDParsons EL, Stratton RJ, Cawood AL, Smith TR, Elia M. Oral nutritional supplements in a randomised trial are more effective than dietary advice at improving quality of life in malnourished care home residents. Clin Nutr. 2017 Feb;36(1):134-142. doi: 10.1016/j.clnu.2016.01.002. Epub 2016 Jan 11.
PMID: 26847947BACKGROUNDElia M, Normand C, Norman K, Laviano A. A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in the hospital setting. Clin Nutr. 2016 Apr;35(2):370-380. doi: 10.1016/j.clnu.2015.05.010. Epub 2015 May 29.
PMID: 26123475BACKGROUNDAlvarez-Hernandez J, Planas Vila M, Leon-Sanz M, Garcia de Lorenzo A, Celaya-Perez S, Garcia-Lorda P, Araujo K, Sarto Guerri B; PREDyCES researchers. Prevalence and costs of malnutrition in hospitalized patients; the PREDyCES Study. Nutr Hosp. 2012 Jul-Aug;27(4):1049-59. doi: 10.3305/nh.2012.27.4.5986.
PMID: 23165541BACKGROUNDPhilipson TJ, Snider JT, Lakdawalla DN, Stryckman B, Goldman DP. Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care. 2013 Feb;19(2):121-8.
PMID: 23448109BACKGROUNDMartin J, Larrea N, Garcia Y, Bolinaga I, Perales A, Sarasqueta C, Quintana JM. One-year post-discharge health-related quality of life in digestive and oncology patients: a three-group comparison by nutritional status and care. Qual Life Res. 2025 Dec 26;35(1):10. doi: 10.1007/s11136-025-04139-y.
PMID: 41452524DERIVEDGarcia Y, Larrea N, Martin J, Bolinaga I, Sarasqueta C, Perales A, Iglesias NC, Yoldi A, Quintana JM; REDISSEC-Malnutrition Research Group. Evaluation of clinical outcomes after an intervention in malnourished hospitalized patients. Clin Nutr. 2025 Nov;54:42-52. doi: 10.1016/j.clnu.2025.04.034. Epub 2025 Sep 18.
PMID: 41004975DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Natalia Covadonga Iglesias, MD
Hospital Universitario Basurto
- STUDY CHAIR
Alfredo Yoldi, MD
Hospital Donostia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Research Unit
Study Record Dates
First Submitted
December 2, 2019
First Posted
December 6, 2019
Study Start
June 15, 2020
Primary Completion
June 30, 2022
Study Completion
June 30, 2023
Last Updated
September 21, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- After december 2024
- Access Criteria
- By demand and agreement with our institutions
Data from the study will be available after main publications